Effects of chronic exposure to low-level cadmium on renal tubular function and CYP2A6-mediated coumarin metabolism in healthy human subjects

Toxicology Letters

Volumn 148, Issue 3, 2004, Pages 187-197

  Satarug, Soisungwan ^a   Nishijo, Muneko ^b   Ujjin, Pailin ^c   Vanavanitkun, Yuvaree ^c   Baker, Jason R ^d   Moore, Michael R ^a,e  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

^c CHULALONGKORN UNIVERSITY   (Thailand)

^d FLINDERS UNIVERSITY   (Australia)

^e QUEENSLAND HEALTH   (Australia)

Author keywords

2 Microglobulin; Cadmium; Coumarin; Cytochrome P450 2A6; Environmental exposure; N Acetyl D glucosaminidase; Nicotine; Proteinuria

Indexed keywords

CADMIUM; COUMARIN; CREATININE; CYTOCHROME; CYTOCHROME P450 2A6; LIVER PROTEIN; MARKER; N ACETYL BETA GLUCOSAMINIDASE; UMBELLIFERONE;

ADULT; ARTICLE; BODY BURDEN; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; HUMAN; KIDNEY; KIDNEY FUNCTION; KIDNEY TUBULE FUNCTION; LIVER; LONG TERM EXPOSURE; METABOLISM; NORMAL HUMAN; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRENGTH; URINARY EXCRETION;

ADULT; ANTICOAGULANTS; ARYL HYDROCARBON HYDROXYLASES; CADMIUM; CADMIUM POISONING; COUMARINS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; KIDNEY TUBULES; MALE; MASS SPECTROMETRY; MIDDLE AGED; MIXED FUNCTION OXYGENASES; UMBELLIFERONES;

THAIS; URIA;

EID: 1642383654     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2003.10.028     Document Type: Article

References (40)

1. Abu-Bakar, A., Satarug, S., Marks, G., Lang, M.A., Moore, M.R., 2004. Role for Nrf2 in cadmium induction of murine cytochrome P450 2A5 gene expression. Toxicol. Lett. 148, 199-210.
2. Baker J.R., Satarug S., Reilly P.E.B., Edwards R.J., Ariyoshi N., Kamataki T., Moore M.R., Williams D.J. Relationships between non-occupational cadmium exposure and expression of nine cytochrome P450 forms in postmortem liver and kidney cortex samples. Biochem. Pharmacol. 62:2001;713-721.
3. Baker J.R., Satarug S., Urbenjapol S., Edwards R.J., Williams D.J., Moore M.R., Reilly P.E.B. Association between human liver and kidney cadmium content and immunochemically detected CYP4A11 apoprotein. Biochem. Pharmacol. 63:2002;695-698.
4. Baker J.R., Satarug S., Urbenjapol S., Edwards R.J., Williams D.J., Moore M.R., Reilly P.E.B. Potential for early involvement of CYP isoforms in aspects of human cadmium toxicity. Toxicol. Lett. 137:2003;85-93.
5. Boobis A.R., Edwards R.J., Adams D.A., Davies D.S. Dissecting the function of cytochrome P450. Br. J. Clin Pharmacol. 42:1996;81-89.
6. Buchet J.P., Lauwerys R., Roels H., Bernard A., Bruaux P., Claeys F., Ducoffre G., Plaen P.D., Staessen J., Amery A., Lijnen P., Thijs L., Rondia D., Sartor F., Remy A.S., Nick L. Renal effects of cadmium body burden of the general population. Lancet. 336:1990;699-702.
7. Cai Y., Aoshima K., Katoh T., Teranishi H., Kasuya M. Renal tubular dysfunction in male inhabitants of a cadmium-polluted area in Toyama, Japan-an eleven year-follow-up study. J. Epidemiol. 11:2001;180-189.
8. Foulkes E.C. The concept of critical levels of toxic heavy metals in target tissues. Crit. Rev. Toxicol. 20:1993;327-339.
9. Gal A., Dreano Y., Gervasi P.G., Berthou F. Human cytochrome P450 2A6 is the major enzyme involved in the metabolism of three alkoxyethers use as oxyfuels. Toxicol. Lett. 124:2000;47-58.
10. Galal-Gorchev H. Dietary intake, levels in food and estimated intake of lead, cadmium and mercury. Food Addit. Contam. 10:1993;115-128.
11. Hayano M., Honda R., Nogawa K., Turitani I., Kido T., Kobayashi E. Dose-response relationship between urinary cadmium concentration and -2-microglobulin using logistic regression analysis. Arch. Environ. Health. 51:1996;162-166.
12. Hellstrom L., Elinder C.G., Dahlberg B., Lundberg M., Jarup L., Persson B., Axelson O. Cadmium exposure and end-stage renal disease. Am. J. Kidney Dis. 38:2001;1001-1008.
13. Ikeda M., Zhang Z.W., Moon C.S., Shimbo S., Watanabe T., Nakatsuka H., Matsuda-Inoguchi N., Higashikawa K. Possible effects of environmental cadmium exposure on kidney function in the Japanese general population. Int. Arch. Occup. Environ. Health. 73:2000;15-25.
14. IPCS, 1992. International Programme on Chemical Safety, Environmental Health Criteria 134, Cadmium. WHO, Geneva.
15. Jarup L., Berglund M., Elinder C., Nordberg G., Vahter M. Health effects of cadmium exposure: a review of literature and a risk estimate. Scand. J. Work Environ. Health. 24(Suppl.):1998;1-52.
16. Jarup L., Hellstrom L., Alfven T., Carlsson M.D., Grubb A., Persson B., Pettersson C., Spang G., Schutz G., Elinder C.G. Low level exposure to cadmium and early kidney damage: the OSCAR study. Occup. Environ. Med. 57:2000;668-672.
17. Jin Y.H., Clark A.B., Slebos R.J., Al-Refai H., Taylor J.A., Kunkel T.A., Resnick M.A., Gordenin D.A. Cadmium is a mutagen that acts by inbibiting mismatch repair. Nat. Genet. 34:2003;326-329.
18. Jin T., Nordberg G., Wu X., Ye T., Kong Q., Wang Z., Zhuang F., Cai S. Urinary N-acetyl-(-D-glucosaminidase (NAG) isoenzymes as biomarker of renal dysfunction caused by cadmium in a general population. Environ. Res. 81:1999;167-173.
19. Johnson M.D., Kenney N., Stoica A., Hilakivi-Clarke L., Singh B., Chepko G., Clarke R., Sholler P.F., Lirio A.A., Foss C., Reiter R., Trock B., Paik S., Martin M.B. Cadmium mimics the in vivo effects of estrogen in the uterus and mammary gland. Nat. Med. 9:2003;1081-1084.
20. Koskela S., Hakkola J., Hukkanen J., Pelkonen O., Sorri M., Saranen A., Anttila S., Fenandez-Salguero P., Gonzalez F., Raunio H. Expression of CYP2A genes in human liver and extrahepatic tissues. Biochem. Pharmacol. 57:1999;1407-1413.
21. Lauwerys R.R., Bernard A.M., Roels H.A., Buchet J.P. Cadmium: exposure markers as predictors of nephrotoxic effects. Clin. Chem. 40-47:1994;1384-1391.
22. Noonan C.W., Sarasua S.M., Campagna D., Kathman S.J., Lybarger J.A., Mueller P.W. Effects of exposure to low levels of environmental cadmium on renal biomarkers. Environ. Health Perspect. 110:2002;151-155.
23. Miles J.S., McLaren A.W., Forrester L.M., Glancey M.J., Lang M.A., Wolf C.R. Identification of the human liver cytochrome P-450 responsible for coumarin 7-hydroxylase activity. Biochem. J. 267:1990;365-371.
24. Oo Y.K., Kobayashi E., Nogawa K., Kubo Y., Suwazono Y., Kido T., Nakagawa H. Renal effects of cadmium intake in a Japanese general population in two areas unpolluted by cadmium. Arch. Environ. Health. 55:2000;98-103.
25. Orlowski C., Piotrowski J.K., Subys J.K., Gross A. Urinary cadmium as indicator of renal cadmium in humans: an autopsy study. Hum. Exp. Toxicol. 17:1998;302-306.
26. Pelkonen O., Rautio A., Raunio H., Pasanen M. CYP2A6: a human coumarin 7-hydroxlase. Toxicology. 144:2000;139-147.
27. Rautio A., Kraul H., Kojo A., Salmela E., Pelkonen O. Interindividual variability of coumarin 7-hydorxylation in healthy volunteers. Pharmacogenetics. 2:1992;227-233.
28. Satarug S., Lang M.A., Yongvanit P., Sithithaworn P., Mairiang E., Mairiang P., Pelkonen P., Barstch H., Haswell-Elkins M.R. Induction of cytochrome P4502A6 expression in humans by the carcinogenic parasite infection, opisthorchiasis viverrini. Cancer Epidemiol. Biomarkers Prev. 5:1996;795-800.
29. Satarug S., Haswell-Elkins M.R., Moore M.R. Safe levels of cadmium intake to prevent renal toxicity in human subjects. Br. J. Nutr. 84:2000;791-802.
30. Satarug S., Baker J.R., Reilly P.E.B., Moore M.R., Williams D.J. Changes in zinc and copper homeostasis in human livers and kidneys associated with exposure to environmental cadmium. Hum. Exp. Toxicol. 20:2001;205-213.
31. Satarug S., Baker J.R., Reilly P.E.B., Moore M.R., Williams D.J. Cadmium levels in the lung, liver, kidney cortex and urine samples from Australians without occupational exposure to metals. Arch. Environ. Health. 57:2002;69-77.
32. Satarug S., Baker J.R., Urbenjapol S., Haswell-Elkins M.R., Reilly P.E.B., Williams D.J., Moore M.R. A global perspective on cadmium pollution and toxicity in non-occupationally exposed population. Toxicol. Lett. 137:2003;65-83.
33. Staessen J.A., Buchet J.P., Ginucchio G., Lauwerys R.R., Lijnen P., Roels H., Fagard R. Public health implications of environmental exposure to cadmium and lead: an overview of epidemiological studies in Belgium. J. Cardiovasc. Risk. 3:1996;26-41.
34. Suwazono Y., Kobayashi E., Okubo Y., Nogawa K., Kido T., Nakagawa H. Renal effects of cadmium exposure in cadmium non-polluted areas in Japan. Environ. Res. 84:2000;44-55.
35. Thijs L., Staessen J., Amery A., Bruaux P., Buchet J.P., Claeys F., De-Plaen P., Ducoffre G., Lauwerys R., Lijnen P. Determinants of serum zinc in a random population sample of four Belgian towns with different degrees of environmental exposure and body burden. Environ. Health Perspect. 98:1993;251-258.
36. Ujjin P., Satarug S., Vanavanitkun Y., Daigo S., Ariyoshi N., Yamazaki H., Reilly P.E.B., Moore M.R., Kamataki T. Variation in coumarin 7-hydroxylase activity associated with genetic polymorphism of cytochrome P450 2A6 and the body status of iron stores in adult Thai males and females. Pharmacogenetics. 12:2002;241-249.
37. Waters D.G., Lake B.G., Cottrell R.C. High performance liquid chromatography of coumarin and its metabolites. J. Chromatogr. 196:1980;501-505.
38. WHO, 1989. Evaluation of certain food additives and contaminants. Thirty-third Report of the Joint FAO/WHO Expert Committee on Food Additives, WHO Technical Report Series No. 776. World Health Organization, Geneva, pp. 28-31.
39. Wrighton S.A., VandenBranden M., Ring B.J. The human drug metabolizing cytochrome P450. J. Phamacokinet. Biopharm. 24:1996;461-473.
40. Yamanaka O., Kobayashi E., Nogawa K., Suwazono Y., Sakurada I., Kido T. Association between renal effects and cadmium exposure in cadmium-nonpolluted area in Japan. Environ. Res. 77:1998;1-8.